These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 3132281
21. Five-aminosalicylic acid enemas in treatment of ulcerative colitis. Fedotin MS. Mo Med; 1985 Jun; 82(6):301-3. PubMed ID: 4010664 [No Abstract] [Full Text] [Related]
22. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis. Abdullah AM, Scott RB, Martin SR. J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):441-4. PubMed ID: 8145103 [No Abstract] [Full Text] [Related]
24. Balsalazide disodium. Am J Health Syst Pharm; 2002 Jan 01; 59(1):27. PubMed ID: 11813462 [No Abstract] [Full Text] [Related]
25. Lung disease associated with orally administered mesalamine for ulcerative colitis. Reinoso MA, Schroeder KW, Pisani RJ. Chest; 1992 May 01; 101(5):1469-71. PubMed ID: 1582327 [Abstract] [Full Text] [Related]
26. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease]. Bayerdörffer E, Bock H. Leber Magen Darm; 1988 Apr 01; 18(2):104-13. PubMed ID: 3374251 [Abstract] [Full Text] [Related]
28. Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis. Austin CA, Cann PA, Jones TH, Holdsworth CD. Lancet; 1984 Apr 21; 1(8382):917-8. PubMed ID: 6143230 [No Abstract] [Full Text] [Related]
29. Therapeutic effectiveness and tolerance of 5-aminosalicylic acid in short term treatment of patients with ulcerative colitis at a low or medium phase of activity. Bresci G, Carrai M, Venturini G, Gambardella L. Int J Tissue React; 1990 Apr 21; 12(4):243-6. PubMed ID: 1980911 [Abstract] [Full Text] [Related]
33. Mesalamine-induced lung toxicity. Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Am J Gastroenterol; 1996 May 21; 91(5):1039-40. PubMed ID: 8633548 [Abstract] [Full Text] [Related]
34. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine. Perrot S, Aslangul E, Szwebel T, Gadhoum H, Romnicianu S, Le Jeunne C. Int J Colorectal Dis; 2007 Sep 21; 22(9):1119-21. PubMed ID: 17440739 [Abstract] [Full Text] [Related]
35. 5-aminosalicylic acid based drugs for the treatment of ulcerative colitis. Järnerot G. Acta Gastroenterol Belg; 1987 Sep 21; 50(3):306-15. PubMed ID: 2894105 [No Abstract] [Full Text] [Related]
36. [Mesalazine (5-ASA) in ulcerative colitis]. Dybdahl JH. Tidsskr Nor Laegeforen; 1990 Oct 10; 110(24):3130-1. PubMed ID: 2237871 [No Abstract] [Full Text] [Related]
38. [Treatment of hemorrhagic rectocolitis with 5-aminosalicylic acid enema]. Benedittini N, Farinotti R, Rene E, Likforman J, Dauphin A, Mignon M. Presse Med; 1985 Mar 30; 14(13):748. PubMed ID: 3157983 [No Abstract] [Full Text] [Related]
39. [Exanthema in 2 patients with ulcerative colitis treated with Pentasa]. Grøn I, Winther A. Ugeskr Laeger; 1988 Jan 04; 150(1):32. PubMed ID: 2967564 [No Abstract] [Full Text] [Related]
40. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents]. Smilde TJ, van Liebergen FJ, Koolen MI, Gerlag PG, Assmann KJ, Berden JH. Ned Tijdschr Geneeskd; 1994 Dec 17; 138(51):2557-61. PubMed ID: 7830805 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]